| 1 | ALKERAN | [1]  Melphalan Melphalan (Alkeran) | [1]  Melphalan 
                
                    Melphalan
                
             (Alkeran) 💬
 | - | - | [2]  28 28, 60 💬
 | 
| 2 | Carmustine, etoposide, cytarabine, and melphalan (BEAM) (Alkeran) | [4]  Carmustine Carmustine, Cytarabine, Etoposide, Melphalan (Alkeran) | [4]  Etoposide 
                
                    Etoposide
                
            , 
                
                    Cytarabine
                
            , 
                
                    Carmustine
                
            , 
                
                    Melphalan
                
             (Alkeran) 💬
 | [2]  TOP2A TOP2A, TOP2B 💬
 | [1]  Platinum drug resistance Platinum drug resistance 💬 | [1]  13 13 💬
 | 
| 3 | Fludarabine, Melphalan, Thiotepa (Alkeran) | [3]  Fludarabine Fludarabine, Melphalan (Alkeran), Thiotepa | [3]  Melphalan 
                
                    Melphalan
                
             (Alkeran), 
                
                    Thiotepa
                
            , 
                
                    Fludarabine
                
             💬
 | [1]  RRM1 RRM1 💬
 | [6]  Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1]  65 65 💬
 | 
| 4 | Fludarabine/ melphalan (Alkeran) | [2]  Fludarabine Fludarabine, Melphalan (Alkeran) | [2]  Melphalan 
                
                    Melphalan
                
             (Alkeran), 
                
                    Fludarabine
                
             💬
 | [1]  RRM1 RRM1 💬
 | [6]  Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1]  60 60 💬
 | 
| 5 | Melphalan (Alkeran) | [1]  Melphalan Melphalan (Alkeran) | [1]  Melphalan 
                
                    Melphalan
                
             (Alkeran) 💬
 | - | - | [15]  11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬
 | 
| 6 | Melphalan fulfenamide hydrochloride (Alkeran) | [1]  Melphalan Melphalan (Alkeran) | [1]  Melphalan 
                
                    Melphalan
                
             (Alkeran) 💬
 | - | - | [1]  28 28 💬
 | 
| 7 | Melphalan Hydrochloride (Alkeran) | [1]  Melphalan Melphalan (Alkeran) | [1]  Melphalan 
                
                    Melphalan
                
             (Alkeran) 💬
 | - | - | [1]  60 60 💬
 | 
| 8 | Melphalan, thalidomide and dexamethasone (Alkeran) | [3]  Dexamethasone Dexamethasone, Melphalan (Alkeran), Thalidomide | [3]  Dexamethasone 
                
                    Dexamethasone
                
            , 
                
                    Melphalan
                
             (Alkeran), 
                
                    Thalidomide
                
             💬
 | [2]  NR3C1 NR3C1, TNF 💬
 | [68]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  28 28 💬
 | 
| 9 | Melphalan-Flufenamide (Melflufen) (Alkeran) | [2]  Melphalan Melphalan (Alkeran), Melphalan flufenamide | [2]  Melphalan 
                
                    Melphalan
                
             (Alkeran), 
                
                    Melphalan flufenamide
                
             💬
 | - | - | [1]  28 28 💬
 | 
| 10 | Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan (Alkeran) | [4]  Alemtuzumab Alemtuzumab, Fludarabine, Melphalan (Alkeran), Thiotepa | [4]  Melphalan 
                
                    Melphalan
                
             (Alkeran), 
                
                    Thiotepa
                
            , 
                
                    Alemtuzumab
                
            , 
                
                    Fludarabine
                
             💬
 | [2]  CD52 CD52, RRM1 💬
 | [6]  Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2]  65 65, 164 💬
 |